Product Name :
Bimiralisib (PQR309)
CAS No.:
1225037-39-7
Purity :
> 99%
Shipping:
Shipped on dry ice.
Storage :
Powder: -20 °C, 3 years; 4 °C, 2 yearsIn solvent: -80 °C, 6 months; -20 °C, 1 month
SMILES:
NC1=NC=C(C2=NC(=NC(=N2)N3CCOCC3)N4CCOCC4)C(=C1)C(F)(F)F
Product Description :
Bimiralisib (PQR309) is a novel brain-penetrant dual PI3K/mTOR inhibitor with in vitro and in vivo antilymphoma activity.{{1290543-63-3} MedChemExpress|{1290543-63-3} Purity & Documentation|{1290543-63-3} Description|{1290543-63-3} custom synthesis} It displays excellent selectivity versus PI3K-related lipid kinases, protein kinases and unrelated targets.
Formula:
C17H20F3N7O2
Molecular Weight :
411.{{1826843-81-5} medchemexpress|{1826843-81-5} Purity & Documentation|{1826843-81-5} In stock|{1826843-81-5} manufacturer} 38
Synonyms:
Additional Information:
|CAS No.PMID:30844158 1225037-39-7 ; |Formula C17H20F3N7O2 ; |Molecular Weight 411.38 ; |SMILES NC1=NC=C(C2=NC(=NC(=N2)N3CCOCC3)N4CCOCC4)C(=C1)C(F)(F)F ; |Target mTOR ; |Product Description Bimiralisib (PQR309) is a novel brain-penetrant dual PI3K/mTOR inhibitor with in vitro and in vivo antilymphoma activity. It displays excellent selectivity versus PI3K-related lipid kinases, protein kinases and unrelated targets. ; |Purity > 99% ; |Shipping Shipped on dry ice. ; |Storage Powder: -20 °C, 3 years; 4 °C, 2 yearsIn solvent: -80 °C, 6 months; -20 °C, 1 month ; |Solubility Overview Soluble in DMSO